Medifast, Inc.
MED
$12.86
-$0.26-1.98%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | -15.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | -15.10% | |||
| Cost of Revenue | 2.27% | -10.74% | |||
| Gross Profit | -4.50% | -16.52% | |||
| SG&A Expenses | -1.98% | -15.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.10% | -14.32% | |||
| Operating Income | -278.00% | -66.33% | |||
| Income Before Tax | -58.75% | -19.20% | |||
| Income Tax Expenses | 173.84% | 5.57% | |||
| Earnings from Continuing Operations | -196.38% | -29.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -196.38% | -29.05% | |||
| EBIT | -278.00% | -66.33% | |||
| EBITDA | -84.58% | 490.25% | |||
| EPS Basic | -196.31% | -29.07% | |||
| Normalized Basic EPS | -58.85% | -19.18% | |||
| EPS Diluted | -200.86% | -30.10% | |||
| Normalized Diluted EPS | -58.68% | -19.24% | |||
| Average Basic Shares Outstanding | 0.09% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.32% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||